4.2 Article

ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux

Ganesh Pai Bellare et al.

Summary: This study proposes the usage of resveratrol as a chemosensitizer in combination with talazoparib for targeting HR proficient breast cancers. Resveratrol effectively enhances talazoparib-induced cell death in breast cancer cells and shows minimal cytotoxicity in normal cells.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Chemistry, Medicinal

Discovery of novel PARP/PI3K dual inhibitors with high efficiency against BRCA-proficient triple negative breast cancer

Junwei Wang et al.

Summary: Co-targeting PARP and PI3K with dual inhibitors is a promising strategy for treating triple negative breast cancer. Compound 12, a novel PARP/PI3K dual inhibitor, exhibits superior antiproliferative effects and excellent antitumor efficacy in animal models.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Oncology

Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

Xin Peng et al.

Summary: This study elucidated the synergistic effect of HCQ and BKM120 in increasing DSBs in tumor cells, enhancing apoptosis and antitumor efficacy. The findings provide new insights into the mechanisms of how HCQ exhibits antitumor effects and synergizes with PI3Ki BKM120 in cancer treatment.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Medicine, Research & Experimental

Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway

Shan Zhu et al.

Summary: This study demonstrated the anti-proliferative and anti-metastatic activities of palmitic acid on human prostate cancer cells, potentially through targeting the PI3K/Akt pathway.

LIFE SCIENCES (2021)

Article Oncology

The PI3K/mTOR Inhibitor Ompalisib Suppresses Nonhomologous End Joining and Sensitizes Cancer Cells to Radio- and Chemotherapy

Jie Du et al.

Summary: NHEJ, the predominant pathway for DNA repair, needs inhibitors to enhance the efficacy of radiotherapy and chemotherapy. Through screening, omipalisib was identified as an effective sensitizer for cell death induced by DNA damage, suppressing the NHEJ pathway.

MOLECULAR CANCER RESEARCH (2021)

Article Cell Biology

BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair

Shaolu Zhang et al.

Summary: This study demonstrated synergistic anticancer effects of PARP inhibitor and PI3K inhibitor on GBM cells, affecting HR molecule expression, repair efficiency, and apoptosis induction. The combination therapy showed significantly increased anti-tumor efficacy in cell and animal models, with complemented DNA damage response and drug accumulation. This combination therapy might represent a promising therapeutic approach for GBM.

CELL DEATH & DISEASE (2021)

Review Biochemistry & Molecular Biology

Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma

Alessandra Ferri et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway

Chunhua Wei et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Pharmacology & Pharmacy

Current Challenges and Opportunities in Treating Glioblastoma

Andrea Shergalis et al.

PHARMACOLOGICAL REVIEWS (2018)

Review Clinical Neurology

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Shabierjiang Jiapaer et al.

NEUROLOGIA MEDICO-CHIRURGICA (2018)

Review Biochemistry & Molecular Biology

ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response

Andrew N. Blackford et al.

MOLECULAR CELL (2017)

Review Pharmacology & Pharmacy

Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy

Wennan Zhao et al.

ACTA PHARMACEUTICA SINICA B (2017)

Article Multidisciplinary Sciences

Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion

Ashish Juvekar et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Oncology

Glioblastoma: Overview of Disease and Treatment

Mary Elizabeth Davis

CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)

Review Biochemistry & Molecular Biology

Mechanisms of ATM Activation

Tanya T. Paull

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)

Article Oncology

Phase II study of PX-866 in recurrent glioblastoma

Marshall W. Pitz et al.

NEURO-ONCOLOGY (2015)

Review Medicine, General & Internal

Glioblastoma and Other Malignant Gliomas A Clinical Review

Antonio Omuro et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Review Oncology

Current clinical development of PI3K pathway inhibitors in glioblastoma

Patrick Y. Wen et al.

NEURO-ONCOLOGY (2012)

Review Chemistry, Multidisciplinary

ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system

De-xin Kong et al.

ACTA PHARMACOLOGICA SINICA (2010)

Article Multidisciplinary Sciences

Nuclear phosphoinositide 3-kinase β controls double-strand break DNA repair

Amit Kumar et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Cell Biology

Homologous recombination in DNA repair and DNA damage tolerance

Xuan Li et al.

CELL RESEARCH (2008)

Article Biochemistry & Molecular Biology

Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation

Gary D. Kao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Genetics & Heredity

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

Jeffrey A. Engelman et al.

NATURE REVIEWS GENETICS (2006)

Article Biochemistry & Molecular Biology

Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase

JH Feng et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

c-Myc directly regulates the transcription of the NBS1 gene involved in DNA double-strand break repair

YC Chiang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)